Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Elias

Showing results (341-350 of 475) with videos related to

Pageof 48
Sort By:
Journal of the National Cancer Institute|April 7, 1993
Intensive combined modality therapy for limited-stage small-cell lung cancerA D Elias, L Ayash, E Frei, et al.
Chest|April 1, 1993
High-dose combined alkylating agent therapy with autologous stem cell support and chest radiotherapy for limited small-cell lung cancerA D Elias, L Ayash, A T Skarin, et al.
Seminars in Oncology|October 1, 1994
High-dose ifosfamide/carboplatin/etoposide with autologous hematopoietic stem cell support: safety and future directionsA D Elias, L J Ayash, C Wheeler, et al.
The Canadian Journal of Cardiology|June 6, 2021
Kawasaki Disease Shock Syndrome vs Classical Kawasaki Disease: A Meta-analysis and Comparison With SARS-CoV-2 Multisystem Inflammatory SyndromeLoubna Lamrani, Cedric Manlhiot, Matthew D Elias, et al.
Cancer|May 15, 1993
Cisplatin, 5-fluorouracil, and etoposide for advanced non-small cell lung cancerT J Lynch, F Kass, L A Kalish, et al.
Transfusion|September 1, 1996
Sources and sequelae of bacterial contamination of hematopoietic stem cell components: implications for the safety of hematotherapy and graft engineeringI J Webb, F S Coral, J W Andersen, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Phase I and pharmacological study of intra-arterial hepatic administration of pirarubicin in patients with advanced hepatic metastasesJ N Munck, P Rougier, G G Chabot, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1991
Escalating doses of carboplatin with high-dose ifosfamide using autologous bone marrow as support: a phase I studyA D Elias, L J Ayash, J P Eder, et al.
Hormones & Cancer|January 18, 2018
Harnessing a Different Dependency: How to Identify and Target Androgen Receptor-Positive Versus Quadruple-Negative Breast CancerJessica L Christenson, Jane B Trepel, Haythem Y Ali, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 16, 2004
Heated intra-operative intraperitoneal oxaliplatin plus irinotecan after complete resection of peritoneal carcinomatosis: pharmacokinetics, tissue distribution and toleranceD Elias, T Matsuhisa, L Sideris, et al.
Pageof 48

Showing results (341-350 of 475) with videos related to

Sort By:
Pageof 48
Journal of the National Cancer Institute|April 7, 1993
Intensive combined modality therapy for limited-stage small-cell lung cancerA D Elias, L Ayash, E Frei, et al.
Chest|April 1, 1993
High-dose combined alkylating agent therapy with autologous stem cell support and chest radiotherapy for limited small-cell lung cancerA D Elias, L Ayash, A T Skarin, et al.
Seminars in Oncology|October 1, 1994
High-dose ifosfamide/carboplatin/etoposide with autologous hematopoietic stem cell support: safety and future directionsA D Elias, L J Ayash, C Wheeler, et al.
The Canadian Journal of Cardiology|June 6, 2021
Kawasaki Disease Shock Syndrome vs Classical Kawasaki Disease: A Meta-analysis and Comparison With SARS-CoV-2 Multisystem Inflammatory SyndromeLoubna Lamrani, Cedric Manlhiot, Matthew D Elias, et al.
Cancer|May 15, 1993
Cisplatin, 5-fluorouracil, and etoposide for advanced non-small cell lung cancerT J Lynch, F Kass, L A Kalish, et al.
Transfusion|September 1, 1996
Sources and sequelae of bacterial contamination of hematopoietic stem cell components: implications for the safety of hematotherapy and graft engineeringI J Webb, F S Coral, J W Andersen, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Phase I and pharmacological study of intra-arterial hepatic administration of pirarubicin in patients with advanced hepatic metastasesJ N Munck, P Rougier, G G Chabot, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1991
Escalating doses of carboplatin with high-dose ifosfamide using autologous bone marrow as support: a phase I studyA D Elias, L J Ayash, J P Eder, et al.
Hormones & Cancer|January 18, 2018
Harnessing a Different Dependency: How to Identify and Target Androgen Receptor-Positive Versus Quadruple-Negative Breast CancerJessica L Christenson, Jane B Trepel, Haythem Y Ali, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 16, 2004
Heated intra-operative intraperitoneal oxaliplatin plus irinotecan after complete resection of peritoneal carcinomatosis: pharmacokinetics, tissue distribution and toleranceD Elias, T Matsuhisa, L Sideris, et al.
Pageof 48